STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more

Johnson & Johnson has decided not to enter the obesity market, focusing instead on cancer research and acquiring Halda Therapeutics for prostate cancer therapy. The FDA approved GSK's antibiotic Utebzi for treating drug-resistant infections, and the article mentions an FDA review of Moderna's flu shot.